208 related articles for article (PubMed ID: 1981824)
1. Impaired immunity in AIDS. The mechanisms responsible and their potential reversal by antiviral therapy.
Ruegg CL; Engleman EG
Ann N Y Acad Sci; 1990; 616():307-17. PubMed ID: 1981824
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of lymphopenia in HIV infection].
Roger PM; Pradier C; Dellamonica P
Presse Med; 1994 Jan; 23(2):89-94. PubMed ID: 7908132
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immune dysfunction in AIDS pathogenesis.
Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
[TBL] [Abstract][Full Text] [Related]
4. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
5. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
[TBL] [Abstract][Full Text] [Related]
6. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
Aiuti F; Mezzaroma I
AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus and acquired immunodeficiency syndrome: an update.
Schnittman SM; Fauci AS
Adv Intern Med; 1994; 39():305-55. PubMed ID: 8140958
[TBL] [Abstract][Full Text] [Related]
8. CD4+ lymphocyte function with early human immunodeficiency virus infection.
Gurley RJ; Ikeuchi K; Byrn RA; Anderson K; Groopman JE
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1993-7. PubMed ID: 2564677
[TBL] [Abstract][Full Text] [Related]
9. Role of CD4 in normal immunity and HIV infection.
Lifson JD; Engleman EG
Immunol Rev; 1989 Jun; 109():93-117. PubMed ID: 2475427
[TBL] [Abstract][Full Text] [Related]
10. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
11. Decreased stimulation of CD4+ T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cells.
Kawamura T; Gatanaga H; Borris DL; Connors M; Mitsuya H; Blauvelt A
J Immunol; 2003 Apr; 170(8):4260-6. PubMed ID: 12682260
[TBL] [Abstract][Full Text] [Related]
12. Will killing the last HIV1 particle cure AIDS patients? II: Second Part. Decrease of viral load and of T-suppressor cells, and increase of the cytotoxic cells, without effect on CD4, after the use of 10 virostatics applied in 3 or 4 drug combinations of different sequences. The time for CD4 immunotherapy?
Mathé G; Colasanté U; Morette C; Hallard M; Blanquet D
Biomed Pharmacother; 1996; 50(10):473-9. PubMed ID: 9091060
[TBL] [Abstract][Full Text] [Related]
13. Diverse repertoire of HIV-1 p24-specific, IFN-gamma-producing CD4+ T cell clones following immune reconstitution on highly active antiretroviral therapy.
Boritz E; Palmer BE; Livingston B; Sette A; Wilson CC
J Immunol; 2003 Jan; 170(2):1106-16. PubMed ID: 12517980
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS.
Alimonti JB; Ball TB; Fowke KR
J Gen Virol; 2003 Jul; 84(Pt 7):1649-1661. PubMed ID: 12810858
[TBL] [Abstract][Full Text] [Related]
15. Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy.
Gougeon ML; Montagnier L
Ann N Y Acad Sci; 1999; 887():199-212. PubMed ID: 10668476
[TBL] [Abstract][Full Text] [Related]
16. Differential susceptibility to monomeric HIV gp120-mediated apoptosis in antigen-activated CD4+ T cell populations.
Tuosto L; Gilardini Montani MS; Lorenzetti S; Cundari E; Moretti S; Lombardi G; Piccolella E
Eur J Immunol; 1995 Oct; 25(10):2907-16. PubMed ID: 7589091
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.
Poznansky MC; Foxall R; Mhashilkar A; Coker R; Jones S; Ramstedt U; Marasco W
Hum Gene Ther; 1998 Mar; 9(4):487-96. PubMed ID: 9525310
[TBL] [Abstract][Full Text] [Related]
18. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
Capobianchi MR
J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
[TBL] [Abstract][Full Text] [Related]
19. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
Tomescu C; Tebas P; Montaner LJ
AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
[TBL] [Abstract][Full Text] [Related]
20. HIV Persistence in Adipose Tissue Reservoirs.
Couturier J; Lewis DE
Curr HIV/AIDS Rep; 2018 Feb; 15(1):60-71. PubMed ID: 29423731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
